Keni, Shubham published the artcileBenzimidazole: a propitious scaffold with multifarious therapeutic potential, Recommanded Product: 1,2-Diphenyl-1H-benzo[d]imidazole, the publication is European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(11), 483-488, database is CAplus.
A review is presented on the antibacterial, antifungal, antiviral, antiinflammatory, antihypertensive activity of benzimidazole derivatives as drug. Most of the drugs and pharmacol. active moieties possess heterocyclic ring structure and presence of hetero atoms or groupings evinces privileged specificities in their pharmacol. targets. Among the heterocyclic compounds, benzimidazole has emerged as cardinal construction motif, which plays pivotal role in drug development. Benzimidazole scaffold is known to possess some prime pharmacol. activities like anti- mycobacterial, antimicrobial, anti-viral, antioxidant, antiinflammatory, antihypertensive, etc. This broad spectrum of biol. and biochem. activities was further assisted by the synthetic flexibility of benzimidazole, which permits development of large no of structurally diverse derivatives Therefore, it is necessary to compile the latest information along with earlier information to understand present status of benzimidazole nucleus in drug discovery. In the present review, various derivatives of benzimidazole possessing anti-mycobacterial, antimicrobial, analgesic and antiinflammatory potential are brought into limelight and their activity was elucidated in accordance with structure activity relation studies.
European Journal of Biomedical and Pharmaceutical Sciences published new progress about 2622-67-5. 2622-67-5 belongs to imidazoles-derivatives, auxiliary class Benzimidazole,Benzene,Benzimidazole, name is 1,2-Diphenyl-1H-benzo[d]imidazole, and the molecular formula is C19H14N2, Recommanded Product: 1,2-Diphenyl-1H-benzo[d]imidazole.
Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem